Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.54 USD | +6.67% | +5.07% | -19.81% |
02:56pm | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
15/04 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
MarketScreener Editorial Features
Today on Wall Street: The start of a new phase | June 30, 2021 at 06:17 pm IST | |
ANALYST RECOMMENDATIONS : Apple, FedEx, Intellia Therapeutics, Reckitt Benckiser, XPO Logistics... | June 30, 2021 at 03:42 pm IST |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- MarketScreener Editorial Features